Competition Law and Policy in the Japanese Pharmaceutical Sector

This  is the first book published that focuses on competition law and policy  in the Japanese pharmaceutical sector. It consists of chapters written  and edited by academics who research the industry from various  perspectives, including economics, competition law, pharmaceutical  regulations, and intellectual property law.
Competition policies  involving pharmaceutical products attract attention from academics and  policymakers worldwide. The pharmaceutical industry is regulated by drug  laws that vary from country to country and are affected by differing  practices and industrial structures. The book begins by examining drug  regulations and trade practices in the industry that are peculiar to  Japan and its healthcare system. It then presents the Japanese  Antimonopoly Act and cases involving it, and discussions of current  competition law issues in the Japanese pharmaceutical industry. The book  also discusses innovation and intellectual property and economic  analyses of pharmaceutical regulations and drug discovery. The chapters  include comparative studies on Japanese regulations vs. those in the  European Union and the United States.
Japan is one of the biggest  pharmaceutical markets in the world. With this in mind, the book  provides “one-stop shopping” for anyone interested in pharmaceutical  regulations in the country. Covering the basics but extending to  in-depth explorations of complex problems, this book appeals not only to  students and academics, pharmaceutical companies and regulators, but  also to those dealing with real-world policy issues that encompass  competition policy, intellectual property, and pharmaceutical  regulation.